MedTrace Logo

Action of Synbiotics on Irradiated GI Mucosa in Rectal Cancer Treatment

NCT03420443 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-02-05

No results posted yet for this study

Summary

The aim of this study is to investigate how bacteria and fibre interact with the epithelial cells of the gastrointestinal mucosa to reduce inflammation and to diminish tissue damage caused by radiation therapy to patients diagnosed with rectal cancer.

Conditions

Interventions

DIETARY_SUPPLEMENT

Oat bran

45 g oat bran.

DIETARY_SUPPLEMENT

Oat bran and blueberry husks

13 g freeze dried blueberry husks and 22 g oat bra + probiotic bacteria.

DIETARY_SUPPLEMENT

No oral supplementation

No oral supplementation.

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Bengt Jeppsson, Prof · University of Lund, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2015-11-30
Completion
2015-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03420443 on ClinicalTrials.gov